Effects of sophorae radix on human gastric and colorectal adenocarcinoma cells: sophorae radix and cancer cells

Journal of Pharmacopuncture
Min-Chul KimByung Joo Kim

Abstract

The purpose of this study was to investigate the anti-cancer effects of Sophorae Radix (SR) and doxorubicin (DOX) in human gastric and colorectal adenocarcinoma cells. We used the human gastric and colorectal adenocarcinoma cell lines (MKN-45 and WIDR cells, respectively). We examined cell death by using the MTT(3-[4, 5-dimethylthiazol-2-yl]-2, 5- diphenyltetrazolium bromide) assay and the caspase 3 assay with SR. To examine the inhibitory effects of SR, we performed a cell cycle (sub G1) analysis for the MKN-45 and WIDR cells after three days with SR. The reversibility of SR was examined for one-day to five-day treatments with SR. SR inhibited the growth of MKN-45 and WIDR cells in a dosedependent manner. Also, we showed that SR induced apoptosis in MKN-45 and WIDR cells by using the MTT assay, the caspase 3 assay and the sub-G1 analysis. SR combined with DOX markedly inhibited the growth of MKN-45 and WIDR cells compared to SR or DOX alone. After 3 days of treating MKN-45 and WIDR cells with SR, the fraction of cells in the sub-G1 phase was much higher than that of the control group. Our findings provide insights into unraveling the effects of SR on human gastric and colorectal adenocarcinoma cells and into developing therape...Continue Reading

References

Nov 1, 1992·Chemical & Pharmaceutical Bulletin·Y DingI Kitagawa
May 1, 1990·Journal of Ethnopharmacology·J YamaharaY Tamai
Apr 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T PatelS H Kaufmann
Dec 30, 1998·Journal of Natural Products·E R WooH Park
Jul 27, 1999·The Journal of Biological Chemistry·H Nagase, J F Woessner
Feb 11, 2000·Annals of the New York Academy of Sciences·G J KelloffC C Sigman
Jun 8, 2000·Journal of Natural Products·T H KangY C Kim
Sep 15, 2000·Journal of Immunological Methods·I VermesC Reutelingsperger
Sep 3, 2003·Biological & Pharmaceutical Bulletin·Soo Jin KimHyun Pyo Kim
Feb 22, 2005·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Be-Jen WangChun-Li Su
Jul 2, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M Braun-FalcoJ Ring
Sep 2, 2006·Biological & Pharmaceutical Bulletin·Xiang-Lan PiaoShao-Qing Cai
Mar 22, 2007·Bioorganic & Medicinal Chemistry·Seizo SatoHiroyuki Kawahara
Jun 21, 2008·Acta Pharmacologica Sinica·Supachai YodkeereePornngarm Limtrakul
Dec 26, 2009·Journal of Ethnopharmacology·Jeong Ho JinHyun Pyo Kim
Sep 16, 2011·Helicobacter·Carlos ResendeAri Ristimäki
Jan 24, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Pornsiri PitchakarnTomoyuki Shirai

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
Assay
fluorescence-activated cell sorter
FACS

Software Mentioned

Cell
Quest

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis